NO995513L - N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK- - Google Patents
N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK-Info
- Publication number
- NO995513L NO995513L NO995513A NO995513A NO995513L NO 995513 L NO995513 L NO 995513L NO 995513 A NO995513 A NO 995513A NO 995513 A NO995513 A NO 995513A NO 995513 L NO995513 L NO 995513L
- Authority
- NO
- Norway
- Prior art keywords
- indolecarboxamides
- cck
- triazolyl
- Prior art date
Links
- FCLMQOPBPGRWFM-UHFFFAOYSA-N N-(2H-triazol-4-yl)-1H-indole-2-carboxamide Chemical class N1N=NC(=C1)NC(=O)C=1NC2=CC=CC=C2C=1 FCLMQOPBPGRWFM-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9705850A FR2763337B1 (fr) | 1997-05-13 | 1997-05-13 | Nouveaux derives du triazole, un procede pour leur preparation et compositions pharmaceutiques les contenant |
| PCT/FR1998/000905 WO1998051686A1 (fr) | 1997-05-13 | 1998-05-06 | N-triazolyl-2-indolecarboxamides et leur utilisation comme agonistes de cck-a |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO995513D0 NO995513D0 (no) | 1999-11-11 |
| NO995513L true NO995513L (no) | 2000-01-12 |
Family
ID=9506830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO995513A NO995513L (no) | 1997-05-13 | 1999-11-11 | N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK- |
Country Status (35)
| Country | Link |
|---|---|
| EP (1) | EP0984960B1 (cs) |
| JP (1) | JP2001524980A (cs) |
| KR (1) | KR20010012541A (cs) |
| CN (1) | CN1263528A (cs) |
| AR (1) | AR011729A1 (cs) |
| AT (1) | ATE232207T1 (cs) |
| AU (1) | AU725530B2 (cs) |
| BR (1) | BR9811465A (cs) |
| CA (1) | CA2289573A1 (cs) |
| CO (1) | CO4940485A1 (cs) |
| CZ (1) | CZ289484B6 (cs) |
| DE (1) | DE69811223T2 (cs) |
| DK (1) | DK0984960T3 (cs) |
| DZ (1) | DZ2486A1 (cs) |
| EE (1) | EE9900524A (cs) |
| ES (1) | ES2190081T3 (cs) |
| FR (1) | FR2763337B1 (cs) |
| GT (1) | GT199800068A (cs) |
| HR (1) | HRP980258B1 (cs) |
| HU (1) | HUP0002763A3 (cs) |
| ID (1) | ID22911A (cs) |
| IL (1) | IL132903A0 (cs) |
| IS (1) | IS5235A (cs) |
| NO (1) | NO995513L (cs) |
| NZ (1) | NZ500637A (cs) |
| PL (1) | PL336772A1 (cs) |
| RU (1) | RU2175323C2 (cs) |
| SI (1) | SI0984960T1 (cs) |
| SK (1) | SK154299A3 (cs) |
| TR (1) | TR199902795T2 (cs) |
| TW (1) | TW396155B (cs) |
| UY (1) | UY24997A1 (cs) |
| WO (1) | WO1998051686A1 (cs) |
| YU (1) | YU57999A (cs) |
| ZA (1) | ZA983997B (cs) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2802530B1 (fr) | 1999-12-17 | 2002-02-22 | Sanofi Synthelabo | Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2,4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant |
| FR2815963B1 (fr) * | 2000-10-26 | 2003-02-28 | Sanofi Synthelabo | Nouveaux derives du triazole et les compositions pharmaceutiques les contenant |
| AR031042A1 (es) * | 2000-10-26 | 2003-09-03 | Sanofi Synthelabo | Derivados de triazol y composiciones farmaceuticas que los contienen |
| HUP0004741A2 (hu) * | 2000-11-28 | 2002-12-28 | Sanofi-Synthelabo | Kémiai eljárás tiazolszármazékok előállítására és új intermedier |
| WO2003037332A1 (en) * | 2001-10-12 | 2003-05-08 | Bayer Pharmaceuticals Corporation | Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity |
| EP1314733A1 (en) * | 2001-11-22 | 2003-05-28 | Aventis Pharma Deutschland GmbH | Indole-2-carboxamides as factor Xa inhibitors |
| DE10237722A1 (de) * | 2002-08-17 | 2004-08-19 | Aventis Pharma Deutschland Gmbh | Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase |
| PL375149A1 (en) * | 2002-10-03 | 2005-11-28 | F.Hoffmann-La Roche Ag | Indole-3-carboxamides as glucokinase (gk) activators |
| EP1479677A1 (en) * | 2003-05-19 | 2004-11-24 | Aventis Pharma Deutschland GmbH | New indole derivatives as factor xa inhibitors |
| EP1532980A1 (en) | 2003-11-24 | 2005-05-25 | Novo Nordisk A/S | N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes |
| GB0403038D0 (en) * | 2004-02-11 | 2004-03-17 | Novartis Ag | Organic compounds |
| RU2415134C9 (ru) * | 2005-08-15 | 2011-05-27 | Этерна Центарис ГмбХ | Способ лечения или профилактики физиологических и/или патофизиологических состояний, опосредуемых рецепторами, стимулирующими секрецию гормона роста, триазолы и фармацевтическая композиция на их основе |
| CA2676222A1 (en) * | 2007-01-26 | 2008-07-31 | Merck & Co., Inc. | Substituted aminopyrimidines as cholecystokinin-1 receptor modulators |
| EP2349484A2 (en) * | 2008-07-15 | 2011-08-03 | Novartis AG | Heteroaryl derivatives as dgat1 inhibitors |
| MA33420B1 (fr) * | 2009-06-09 | 2012-07-03 | Actelion Pharmaceuticals Ltd | Dérivés fluorés de l'aminotriazole |
| EP2490658A1 (de) * | 2009-10-22 | 2012-08-29 | Henkel AG & Co. KGaA | Zusammensetzung zur formgebung keratinischer fasern enthaltend mit propylenoxid modifizierte stärke |
| CN106928147A (zh) * | 2017-03-14 | 2017-07-07 | 华东师范大学 | 三环二萜类似物及其制备方法、及其在制备抗前列腺癌药物中的应用 |
| CN107271623A (zh) * | 2017-07-27 | 2017-10-20 | 青岛啤酒股份有限公司 | 基于人体饱腹感的啤酒可饮性评价方法 |
| MX2022004142A (es) | 2019-10-07 | 2022-09-21 | Kallyope Inc | Agonistas de gpr119. |
| TW202140440A (zh) | 2020-02-28 | 2021-11-01 | 美商克力歐普股份有限公司 | Gpr40激動劑 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2701708B1 (fr) * | 1993-02-19 | 1995-05-19 | Sanofi Elf | Dérivés de 2-amido-4-phénylthiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament. |
| FR2703995B1 (fr) * | 1993-04-16 | 1995-07-21 | Sanofi Elf | 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant. |
-
1997
- 1997-05-13 FR FR9705850A patent/FR2763337B1/fr not_active Expired - Fee Related
-
1998
- 1998-05-06 ID IDW991374A patent/ID22911A/id unknown
- 1998-05-06 KR KR1019997010496A patent/KR20010012541A/ko not_active Ceased
- 1998-05-06 CN CN98807175A patent/CN1263528A/zh active Pending
- 1998-05-06 BR BR9811465-4A patent/BR9811465A/pt not_active IP Right Cessation
- 1998-05-06 CZ CZ19994006A patent/CZ289484B6/cs not_active IP Right Cessation
- 1998-05-06 EE EEP199900524A patent/EE9900524A/xx unknown
- 1998-05-06 NZ NZ500637A patent/NZ500637A/xx unknown
- 1998-05-06 ES ES98924383T patent/ES2190081T3/es not_active Expired - Lifetime
- 1998-05-06 JP JP54885398A patent/JP2001524980A/ja not_active Ceased
- 1998-05-06 TR TR1999/02795T patent/TR199902795T2/xx unknown
- 1998-05-06 RU RU99125773/04A patent/RU2175323C2/ru not_active IP Right Cessation
- 1998-05-06 WO PCT/FR1998/000905 patent/WO1998051686A1/fr not_active Ceased
- 1998-05-06 CA CA002289573A patent/CA2289573A1/fr not_active Abandoned
- 1998-05-06 DE DE69811223T patent/DE69811223T2/de not_active Expired - Fee Related
- 1998-05-06 IL IL13290398A patent/IL132903A0/xx unknown
- 1998-05-06 CO CO98024703A patent/CO4940485A1/es unknown
- 1998-05-06 EP EP98924383A patent/EP0984960B1/fr not_active Expired - Lifetime
- 1998-05-06 HU HU0002763A patent/HUP0002763A3/hu unknown
- 1998-05-06 DK DK98924383T patent/DK0984960T3/da active
- 1998-05-06 AT AT98924383T patent/ATE232207T1/de not_active IP Right Cessation
- 1998-05-06 PL PL98336772A patent/PL336772A1/xx unknown
- 1998-05-06 AU AU76599/98A patent/AU725530B2/en not_active Ceased
- 1998-05-06 DZ DZ980096A patent/DZ2486A1/xx active
- 1998-05-06 YU YU57999A patent/YU57999A/sh unknown
- 1998-05-06 SK SK1542-99A patent/SK154299A3/sk unknown
- 1998-05-06 SI SI9830372T patent/SI0984960T1/xx unknown
- 1998-05-11 AR ARP980102152A patent/AR011729A1/es active IP Right Grant
- 1998-05-12 ZA ZA9803997A patent/ZA983997B/xx unknown
- 1998-05-12 UY UY24997A patent/UY24997A1/es not_active IP Right Cessation
- 1998-05-12 TW TW087107326A patent/TW396155B/zh active
- 1998-05-13 HR HR980258A patent/HRP980258B1/xx not_active IP Right Cessation
- 1998-05-20 GT GT199800068A patent/GT199800068A/es unknown
-
1999
- 1999-10-29 IS IS5235A patent/IS5235A/is unknown
- 1999-11-11 NO NO995513A patent/NO995513L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0906292T3 (da) | Triazolylmercaptider og deres anvendelse som mikrobicider | |
| DK1015434T3 (da) | Ny pyrimidin-4-on og pyrimidin-4-thion som fungicid | |
| NO972983D0 (no) | Sulfonamider og deres anvendelse | |
| NO991922L (no) | Heteroarylsuccinamider og deres anvendelse som metalloproteinaseinhibitorer | |
| NO20001323D0 (no) | Dipeptid-apoptose inhibitorer og deres anvendelse | |
| DK1019358T3 (da) | 3,3-diarylpropylaminer, deres anvendelse og fremstilling | |
| NO20021449L (no) | Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og deres anvendelse | |
| DK0832082T3 (da) | N-heteroaryl-pyridinsulfonamidderivater og deres anvendelse som endotelinantagonister | |
| DK0958292T3 (da) | 4-3(3-heterocyclyl-1-benzoyl)pyrazoler og deres anvendelse som herbicider | |
| NO985977D0 (no) | Spiro-piperidinderivater og deres anvendelse som terapeutiske midler | |
| DE69731238D1 (de) | Aufblasbarer hemostat | |
| NO995513L (no) | N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK- | |
| NO20003067D0 (no) | Antipicornavirus-forbindelser og fremgangsmÕter for deres anvendelse og fremstilling | |
| NO971811D0 (no) | Bicykliske tetrahydropyrazolopyridiner og deres anvendelse som legemidler | |
| DK1073672T3 (da) | Antipicornavirale forbindelser, deres fremstilling og anvendelse | |
| NO984761D0 (no) | Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler | |
| DK0989121T3 (da) | Substituerede benzamider og deres anvendelse som immunmodulatorer | |
| DK0770059T3 (da) | Substituerede benzamidiner, deres fremstilling og deres anvendelse som lægemidler | |
| NO994510L (no) | Substituerte isokinolin-derivater og deres anvendelse som antikonvulsanter | |
| NO993467D0 (no) | Granuler som innbefatter klavulanat og en eller flere eksipienter | |
| NO985891D0 (no) | Substituerte benzamid-derivater og deres anvendelse som antikonvulsjonsmidler | |
| DK0764157T3 (da) | Benzopyraner og deres anvendelse som terapeutiske midler | |
| DK1214302T3 (da) | Substituerede 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-oner og deres anvendelse som lipasehæmmere | |
| NO20013085D0 (no) | Fosfororganiske forbindelser og deres anvendelse | |
| NO20003142D0 (no) | Substituerte isokinolin-derivater og anvendelse derav som antikrampemidler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |